REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content)
- Licence status
- Active substances
- Tetanus toxoid, Diphtheria toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin, Polio virus type 1 inactivated, Polio virus type 2 inactivated, Polio virus type 3 inactivated, Adsorbed aluminium phosphate, Adsorbed fimbriae types 2 + 3
- Dosage Form
- Suspension for injection in pre-filled syringe
- Licence number
- PA23458/004/001
- Licence holder
- Sanofi Winthrop Industrie
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- J07CA Bacterial and viral vaccines, combined, J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Batches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC, as amended.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 25/07/2003